I posted about this about 3 weeks ago -- it has now been fast tracked by FDA --
ARV-110, PROTAC® a protein degrader that destroys the AR receptors in PCa
ARV-110 Granted Fast Track Designatio... - Advanced Prostate...
ARV-110 Granted Fast Track Designation From FDA for mCRPC
Written by
George71
To view profiles and participate in discussions please or .
3 Replies
•
Great News...... now if I only knew what it meant...
Good Luck, Good Health and Good Humor.
j-o-h-n Sunday 06/16/2019 11:40 PM DST
Not what you're looking for?
You may also like...
FDA Fast Track Designation for 225Ac-FL-020 for mCRPCa
Another weapon, from Germany this time....ahhhh zee germanz! Actinium strikes again!
Phase 1 trial...
Syncromune Granted FDA Fast-Track Designation for SYNC-T SV-102 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
FORT LAUDERDALE, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Syncromune® Inc., a clinical-stage...
ONCT-534 Earns FDA Fast Track Designation in R/R Metastatic CRPC
ONCT-534 recruiting...
Seviteronel (VT-464) - Durham's Innocrin Nabs FDA Fast Track OK for Prostate Cancer Drug
Does anyone know anything about this drug?
Seviteronel (VT-464) - Durham's Innocrin Nabs FDA Fast...
FDA Grants Fast Track Designation for 177Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
Is this superior to the LU177 now available?...
Related Posts
ARV-110 clear phase 1 for mCRPC very promising.
Clarity Pharmaceuticals gains FDA fast-track status for advanced prostate cancer 64Cu-SAR-bisPSMA imaging -hopefully soon also for treatment
Article: FDA grants 177Lu-PSMA-617 breakthrough designation for mCRPC
FDA just fast-tracked this. Phase IIb is scheduled to be complete in early 2022. Prevents reoccurrence via. immune system T helper cells.
The FDA's Crazy Drug Approval Process Is Killing Guys With PCa
